Evidence map›Paper›PMID 21915337›Full record

ArticlePloS one2011

Delta1 expression, cell cycle exit, and commitment to a specific secretory fate coincide within a few hours in the mouse intestinal stem cell system.

Despina Stamataki, Maxine Holder, Christine Hodgetts, Rosemary Jeffery, Emma Nye, Bradley Spencer-Dene, Douglas J Winton, Julian Lewis

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 85 citations in OpenAlex.

  1. Therapeutic targeting of the NOTCH1 and neddylation pathways in T cell acute lymphoblastic leukemia.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Tissue engineering. Part B, Reviews · 2020
    Review
  14. Stem Cell Signaling Pathways in the Small Intestine.International journal of molecular sciences · 2020
    Review
  15. Article
  16. Preservation of reserve intestinal epithelial stem cells following severe ischemic injury.American journal of physiology. Gastrointestinal and liver physiology · 2019
    Article
  17. Article
  18. Stem Cells in Repair of Gastrointestinal Epithelia.Physiology (Bethesda, Md.) · 2017
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Despina StamatakiVertebrate Development Laboratory, Cancer Research United Kingdom London Research Institute, London, United Kingdom.
Maxine Holder
Christine Hodgetts
Rosemary Jeffery
Emma Nye
Bradley Spencer-Dene
Douglas J Winton
Julian Lewis
Cancer Research UK · GBCancer Research UK Cambridge Center · GB

Funding

Cancer Research UK
6 · The paper itself

Abstract

The stem cells of the small intestine are multipotent: they give rise, via transit-amplifying cell divisions, to large numbers of columnar absorptive cells mixed with much smaller numbers of three different classes of secretory cells--mucus-secreting goblet cells, hormone-secreting enteroendocrine cells, and bactericide-secreting Paneth cells. Notch signaling is known to control commitment to a secretory fate, but why are the secretory cells such a small fraction of the population, and how does the diversity of secretory cell types arise? Using the mouse as our model organism, we find that secretory cells, and only secretory cells, pass through a phase of strong expression of the Notch ligand Delta1 (Dll1). Onset of this Dll1 expression coincides with a block to further cell division and is followed in much less than a cell cycle time by expression of Neurog3--a marker of enteroendocrine fate--or Gfi1--a marker of goblet or Paneth cell fate. By conditional knock-out of Dll1, we confirm that Delta-Notch signaling controls secretory commitment through lateral inhibition. We infer that cells stop dividing as they become committed to a secretory fate, while their neighbors continue dividing, explaining the final excess of absorptive over secretory cells. Our data rule out schemes in which cells first become committed to be secretory, and then diversify through subsequent cell divisions. A simple mathematical model shows how, instead, Notch signaling may simultaneously govern the commitment to be secretory and the choice between alternative modes of secretory differentiation.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsCell CycleCell DifferentiationDNA-Binding ProteinsFemaleImmunohistochemistryIn Situ HybridizationIntestine, SmallIntracellular Signaling Peptides and ProteinsIn Vitro TechniquesMaleMembrane ProteinsMiceModels, TheoreticalNerve Tissue ProteinsBasic Helix-Loop-Helix Proteinsdelta proteinDNA-Binding ProteinsGfi1 protein, mouseIntracellular Signaling Peptides and ProteinsMembrane ProteinsNerve Tissue ProteinsNeurog3 protein, mouseTranscription Factors

Identifiers

PMID21915337
PMCPMC3168508
OpenAlexW2024021974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.